|
|
 Previous Article | Table of Contents | Next Article 
Regulation of the Serum Concentration of Thrombopoietin in Thrombocytopenic NF-E2 Knockout Mice
Ramesh A. Shivdasani,
Paul Fielder,
Gilbert-Andre Keller,
Stuart H. Orkin, and
Frederic J. de Sauvage
From the Departments of Medicine and Pediatric Oncology, Dana-Farber Cancer Institute, Children's Hospital Medical Center, Howard Hughes Medical Institute, and Harvard Medical School, Boston, MA; and the Department of Molecular Oncology and Department of Pharmacokinetics and Metabolism, Genentech Inc, South San Francisco, CA.
The mechanisms that regulate circulating levels of thrombopoietin (Tpo) are incompletely understood. According to one favored model, the rate of Tpo synthesis is constant, whereas the serum concentration of free Tpo is modulated through binding to c-Mpl receptor expressed on blood platelets. Additionally, a role for c-Mpl expressed on megakaryocytes is suggested, particularly by the observation that serum Tpo levels are not elevated in human immune thrombocytopenic purpura. Whereas direct binding of Tpo to platelets has been demonstrated in vitro and in vivo, the role of megakaryocytes in modulating serum Tpo levels has not been addressed experimentally. The profoundly thrombocytopenic mice lacking transcription factor p45 NF-E2 do not show the predicted increase in serum Tpo concentration. To evaluate the fate of the ligand in these animals, we injected 125I-Tpo intravenously into mutant and control mice. In contrast to normal littermates, NF-E2 knockout mice show negligible association of radioactivity with blood cellular components, consistent with an absence of platelets. There is no corresponding increase in plasma-associated radioactivity to suggest persistence in the circulation. However, a greater fraction of the radioligand is bound to hematopoietic tissues. In the bone marrow this is detected virtually exclusively in association with megakaryocytes, whereas in the spleen it is associated with megakaryocytes and small, abnormal, platelet-like particles or megakaryocyte fragments that are found within or in close contact with macrophages. These findings implicate the combination of megakaryocytes and the latter particles as a sink for circulating Tpo in NF-E2 knockout mice, and provide an explanation for the lack of elevated serum Tpo levels in this unique animal model of thrombocytopenia.
Blood, Vol. 90 No. 5 (September 1), 1997:
pp. 1821-1827
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
R. Tiedt, J. Coers, S. Ziegler, A. Wiestner, H. Hao-Shen, C. Bornmann, J. Schenkel, S. Karakhanova, F. J. de Sauvage, C. W. Jackson, et al.
Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes
Blood,
February 19, 2009;
113(8):
1768 - 1777.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Blair, S. Rex, O. Vitseva, L. Beaulieu, K. Tanriverdi, S. Chakrabarti, C. Hayashi, C. A. Genco, M. Iafrati, and J. E. Freedman
Stimulation of Toll-Like Receptor 2 in Human Platelets Induces a Thromboinflammatory Response Through Activation of Phosphoinositide 3-Kinase
Circ. Res.,
February 13, 2009;
104(3):
346 - 354.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Lorenzo, M. Horowitz, and Y. Choi
Osteoimmunology: Interactions of the Bone and Immune System
Endocr. Rev.,
June 1, 2008;
29(4):
403 - 440.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Talebian, Z. Li, Y. Guo, J. Gaudet, M. E. Speck, D. Sugiyama, P. Kaur, W. S. Pear, I. Maillard, and N. A. Speck
T-lymphoid, megakaryocyte, and granulocyte development are sensitive to decreases in CBF{beta} dosage.
Blood,
January 1, 2007;
109(1):
11 - 21.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Nagata, J. Yoshikawa, A. Hashimoto, M. Yamamoto, A. H. Payne, and K. Todokoro
Proplatelet formation of megakaryocytes is triggered by autocrine-synthesized estradiol
Genes & Dev.,
December 1, 2003;
17(23):
2864 - 2869.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. C. Haznedaroglu, H. Goker, M. Turgut, Y. Buyukasik, and M. Benekli
Thrombopoietin as a Drug: Biologic Expectations, Clinical Realities, and Future Directions
Clinical and Applied Thrombosis/Hemostasis,
July 1, 2002;
8(3):
193 - 212.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. Mattia, F. Vulcano, L. Milazzo, A. Barca, G. Macioce, A. Giampaolo, and H. J. Hassan
Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release
Blood,
February 1, 2002;
99(3):
888 - 897.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Battinelli, S. R. Willoughby, T. Foxall, C. R. Valeri, and J. Loscalzo
Induction of platelet formation from megakaryocytoid cells by nitric oxide
PNAS,
December 4, 2001;
98(25):
14458 - 14463.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Sungaran, O. T. Chisholm, B. Markovic, L. M. Khachigian, Y. Tanaka, and B. H. Chong
The role of platelet alpha -granular proteins in the regulation of thrombopoietin messenger RNA expression in human bone marrow stromal cells
Blood,
May 15, 2000;
95(10):
3094 - 3101.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Levin, J.-P. Peng, G. R. Baker, J.-L. Villeval, P. Lecine, S. A. Burstein, and R. A. Shivdasani
Pathophysiology of Thrombocytopenia and Anemia in Mice Lacking Transcription Factor NF-E2
Blood,
November 1, 1999;
94(9):
3037 - 3047.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Cohen-Solal, N. Vitrat, M. Titeux, W. Vainchenker, and F. Wendling
High-Level Expression of Mpl in Platelets and Megakaryocytes Is Independent of Thrombopoietin
Blood,
May 1, 1999;
93(9):
2859 - 2866.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Vyas, K. Ault, C. W. Jackson, S. H. Orkin, and R. A. Shivdasani
Consequences of GATA-1 Deficiency in Megakaryocytes and Platelets
Blood,
May 1, 1999;
93(9):
2867 - 2875.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Poujol, D. T.-L. Roux, P. Tropel, V. Roullot, A. Nurden, G. Marguerie, and P. Nurden
Ultrastructural Analysis of Bone Marrow Hematopoiesis in Mice Transgenic for the Thymidine Kinase Gene Driven by the alpha IIb Promoter
Blood,
September 15, 1998;
92(6):
2012 - 2023.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Hamada, R. Mohle, J. Hesselgesser, J. Hoxie, R. L. Nachman, M. A.S. Moore, and S. Rafii
Transendothelial Migration of Megakaryocytes in Response to Stromal Cell-derived Factor 1 (SDF-1) Enhances Platelet Formation
J. Exp. Med.,
August 3, 1998;
188(3):
539 - 548.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. P. Solar, W. G. Kerr, F. C. Zeigler, D. Hess, C. Donahue, F. J. de Sauvage, and D. L. Eaton
Role of c-mpl in Early Hematopoiesis
Blood,
July 1, 1998;
92(1):
4 - 10.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. S. Sayer, P. A. Tilbrook, A. Spadaccini, E. Ingley, M. K. Sarna, J. H. Williams, N. C. Andrews, and S. P. Klinken
Ectopic Expression of Transcription Factor NF-E2 Alters the Phenotype of Erythroid and Monoblastoid Cells
J. Biol. Chem.,
August 11, 2000;
275(33):
25292 - 25298.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
